Evidence map›Paper›PMID 29213323›Full record

ArticleBiotechnology for biofuels2017

Defined tetra-allelic gene disruption of the 4-coumarate:coenzyme A ligase 1 (Pv4CL1) gene by CRISPR/Cas9 in switchgrass results in lignin reduction and improved sugar release.

Jong-Jin Park, Chang Geun Yoo, Amy Flanagan, Yunqiao Pu, Smriti Debnath, Yaxin Ge, Arthur J Ragauskas, Zeng-Yu Wang

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 119 citations in OpenAlex.

  1. Review
  2. Article
  3. 4-Coumarate CoA Ligase Family in Soybean Responds toCurrent issues in molecular biology · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mutating alfalfaFrontiers in plant science · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Genetic Determinants of Biomass in CFrontiers in plant science · 2022
    Review
  18. Gene Editing Technologies for Sugarcane Improvement: Opportunities and Limitations.Sugar tech : an international journal of sugar crops & related industries · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jong-Jin ParkNoble Research Institute, Ardmore, OK 73401 USA.
Chang Geun YooBioEnergy Science Center, Oak Ridge National Laboratory, Oak Ridge, TN 37831 USA.
Amy FlanaganNoble Research Institute, Ardmore, OK 73401 USA.
Yunqiao PuBioEnergy Science Center, Oak Ridge National Laboratory, Oak Ridge, TN 37831 USA.
Smriti DebnathNoble Research Institute, Ardmore, OK 73401 USA.
Yaxin GeNoble Research Institute, Ardmore, OK 73401 USA.
Arthur J RagauskasBioEnergy Science Center, Oak Ridge National Laboratory, Oak Ridge, TN 37831 USA.
Zeng-Yu WangNoble Research Institute, Ardmore, OK 73401 USA.ORCID 0000-0002-6835-7917
Oak Ridge National Laboratory · USNoble Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe development of genome editing technologies offers new prospects in improving bioenergy crops like switchgrass (

resultsWe developed a CRISPR/Cas9 genome editing system in switchgrass to target a key enzyme involved in the early steps of monolignol biosynthesis, 4-Coumarate:coenzyme A ligase (4CL). Three

conclusionThis study established a successful CRISPR/Cas9 system in switchgrass with mutation efficiency reaching 10%. The system allows the precise targeting of the selected

Indexed as

4CL4-Coumarate:coenzyme A ligaseBioenergyCRISPR/Cas9Genome editingLignin biosynthesisPanicum virgatumSugar releaseSwitchgrass

Identifiers

PMID29213323
PMCPMC5708096
OpenAlexW2770256035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.